WKYT interviewed a participant in a clinical trial at UK’s Sanders-Brown Center on Aging. For two years, Carol Borkowski took an experimental drug called Lecanemab, a drug for patients with mild symptoms of Alzheimer’s Disease. Her husband, Ron, says during that time Carol stabilized and her symptoms did not get worse. Ron remembers how much that meant to him as her husband and caregiver. “I had my Carol back. I didn’t have to worry about tomorrow. Yea you worry, but you could see that hey she’s right in there with you.”
Greg Jicha, MD, PhD, a neurologist at Sanders-Brown, told WKYT that the drug was a huge success during the clinical trial. “It is an antibody that’s been created in the laboratory to remove, dissolve the amyloid plaques that are at the core of Alzheimer’s Disease from the brain.” Dr. Jicha cautions this drug is not a cure, but a critical step forward to finding one. He says, “Carol’s study and the medicine she was taking turned out to be a huge success. Really leading right now to the potential first disease-modifying therapy. Not the eventual cure we’re looking for but the first step in that direction.”
Click here to read more from WKYT.
